EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Double CYP11B1/CYP11B2 Immunohistochemistry and Detection of KCNJ5 Mutations in Primary Aldosteronism

Brasilina Caroccia, Livia Lenzini iD, Giulio Ceolotto iD, Francesca Gioco, Andrea Benetti, Alessandra Giannella, Hala Ajjour, Francesca Galuppini, Gianmaria Pennelli, Teresa Maria Seccia iD, Celso Gomez-Sanchez, Gian Paolo Rossi iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Brasilina Caroccia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Specialized Center of Excellence for Hypertension of the European Society of Hypertension and Emergency Medicine Unit, Department of Medicine-DIMED, …. Hauptthemen laut MEDLINE: Hyperaldosteronism, G Protein-Coupled Inwardly-Rectifying Potassium Channels, Steroid 11-beta-Hydroxylase, Cytochrome P-450 CYP11B2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for advanced Research, In Hypertension and CArdiovascular, DIMAR Excellence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The search for somatic mutations in adrenals resected from patients with primary aldosteronism (PA) is performed by Sanger sequencing, often implemented with immunohistochemistry (IHC)-guidance focused on aldosterone-producing (CYP11B2-positive) areas.

Objective

To investigate the impact of double IHC for CYP11B1 and CYP11B2 on Sanger and next-generation sequencing (NGS).

Methods

We investigated 127 consecutive adrenal aldosterone-producing adenomas from consenting surgically cured PA patients using double IHC for CYP11B1 and CYP11B2, by Sanger sequencing and NGS.

Results

Double IHC for CYP11B2 and CYP11B1 revealed 3 distinct patterns: CYP11B2-positive adenoma (pattern 1), mixed CYP11B1/CYP11B2-positive adenoma (pattern 2), and adrenals with multiple small CYP11B2-positive nodules (pattern 3). Sanger sequencing allowed detection of KCNJ5 mutations in 44% of the adrenals; NGS revealed such mutations in 10% of those negative at Sanger and additional mutations in 61% of the cases. Importantly the rate of KCNJ5 mutations differed across patterns: 17.8% in pattern 1, 71.4% in pattern 2, and 10.7% in pattern 3 (χ2 = 22.492, P < .001).

Conclusion

NGS allowed detection of mutations in many adrenals that tested negative at Sanger sequencing. Moreover, the different distribution of KCNJ5 mutations across IHC patterns indicates that IHC-guided sequencing protocols selecting CYP11B2-positive areas could furnish results that might not be representative of the entire mutational status of the excised adrenal, which is important at a time when KCNJ5 mutations are suggested to drive management of patients with aldosterone-producing adenomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismG Protein-Coupled Inwardly-Rectifying Potassium ChannelsSteroid 11-beta-HydroxylaseCytochrome P-450 CYP11B2MutationImmunohistochemistryHumansFemaleMaleMiddle AgedAdultHigh-Throughput Nucleotide SequencingAdrenocortical AdenomaAgedAdrenal Cortex Neoplasms

Stichwörter der Autor:innen

CYP11B2 immunohistochemistrySanger sequencingkir3.4 channelnext-generation sequencingprimary aldosteronism

Substanzen

KCNJ5 protein, humanG Protein-Coupled Inwardly-Rectifying Potassium ChannelsSteroid 11-beta-HydroxylaseCytochrome P-450 CYP11B2

Autor:innen und Institutionen

  • Specialized Center of Excellence for Hypertension of the European Society of Hypertension and Emergency Medicine Unit, Department of Medicine-DIMED, University of Padua, Padua 35126, Italy.
  • Department of Women's and Children's Health-SBD, University of Padua, Padua 35122, Italy.
  • Division of Thrombotic and Hemorrhagic Diseases, Department of Medicine-DIMED, University of Padua, Padua 35122, Italy.
  • Department of Medicine, Surgical Pathology Unit, University of Padua, Padua 35122, Italy.
  • G.V. (Sonny) Montgomery VA Medical Center and Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA.

ORCID-Profile: Livia Lenzini, Giulio Ceolotto, Teresa Maria Seccia, Gian Paolo Rossi

Förderung

  • Foundation for advanced Research
  • In Hypertension and CArdiovascular
  • DIMAR Excellence
  • Department of Medicine
  • The Foundation for Advanced Research in Hypertension and Cardiovascular Diseases
  • CORIS-Consorzio per la Ricerca Sanitaria
  • University of Padua DOR
  • University of Padua

Zitieren

APA

Caroccia, B., Lenzini, L., Ceolotto, G., Gioco, F., Benetti, A., Giannella, A., Ajjour, H., Galuppini, F., Pennelli, G., Seccia, T. M., Gomez-Sanchez, C., & Rossi, G. P. (2024). Double CYP11B1/CYP11B2 Immunohistochemistry and Detection of KCNJ5 Mutations in Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae411

Vancouver

Caroccia B, Lenzini L, Ceolotto G, Gioco F, Benetti A, Giannella A, et al. Double CYP11B1/CYP11B2 Immunohistochemistry and Detection of KCNJ5 Mutations in Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae411

BibTeX
@article{Caroccia2024,
  author = {Caroccia, Brasilina and Lenzini, Livia and Ceolotto, Giulio and Gioco, Francesca and Benetti, Andrea and Giannella, Alessandra and Ajjour, Hala and Galuppini, Francesca and Pennelli, Gianmaria and Seccia, Teresa Maria and Gomez-Sanchez, Celso and Rossi, Gian Paolo},
  title = {Double CYP11B1/CYP11B2 Immunohistochemistry and Detection of KCNJ5 Mutations in Primary Aldosteronism},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae411}
}
Kostenlos starten →